tirzepatide with levocarnitine Troubling Findings in Study of GLP-1 Compounders tirzepatide/levocarnitine injection Tirzepatide Injection |

Development of biosimilars Biosimilars market is firmly established and constantly growing due to the emergence of new drugs and active ingredients like Liraglutide and Semaglutide

Freezing causes irreversible damage to the peptide structure of GLP-1 medications, destroying their ability to bind to receptors and rendering them therapeutically ineffective

Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons

Please click on the image below to directly access the latest data (R&D Status | Core Patent | Clinical Trial | Approval status in Global countries) of Pfizer

Given that GLP-1 medications often suppress appetite, there is understandable anxiety that widespread use could dampen demand and reduce overall sales